Company news
Racura Oncology Ltd news in 2019
Racura Oncology Ltd's news releases, calls and decks from 2019, newest first.
Race Receives $159k R&D Tax Incentive Refund
December 16, 2019
Race reveals new strategy for cancer drug Bisantrene
November 14, 2019
Appendix 4C - quarterly
October 17, 2019
Prominent biotech investor leads investment in Race
August 19, 2019
First patient treated in Bisantrene trial in Israel
July 24, 2019
Bisantrene AML trial to start in Israel
May 13, 2019
Bisantrene IND Update
April 24, 2019
Race files Bisantrene IND with FDA
March 24, 2019
Principal Investigator appointed for Bisantrene
February 24, 2019
Race Receives $228k R&D Tax Incentive Refund
January 31, 2019
Race appoints leading haematologist to support Bisantrene
January 21, 2019
Decks in 2019
- Race Oncology — Shareholder Meeting (November 2019)
Shareholder meeting · 32 slides · Nov 22, 2019